MARATTO

article · Indian Journal of Medical and Paediatric Oncology

Massive Pulmonary Ewing Sarcoma Mimicking Pulmonary Embolism: A Diagnostic Challenge

2026Open accessMinia University

Abstract

Abstract While classic Ewing sarcoma targets bone, the extra-skeletal variant develops in soft tissues, with a rare incidence of 0.4 per million. Although the chest wall is a recognized site for extra-skeletal Ewing sarcoma, primary pulmonary Ewing sarcoma is exceptionally rare, representing less than 1% of all extra-skeletal Ewing sarcoma cases. An 18-year-old female experienced dyspnea, tachycardia, and cough for 5 months. After not responding to symptomatic therapy, she presented to the emergency department for acute worsening of dyspnea and tachycardia, raising clinical suspicion for pulmonary embolism. Computed tomography revealed a massive pulmonary mass and a pleural effusion. Immunostaining findings were consistent with Ewing sarcoma. She was treated with chemotherapy as per protocol VDC/IE (Vincristine, Doxorubicin, Cyclophosphamide/Ifosfamide, Etoposide). She responded well to therapy, with a marked reduction in tumor size. Pulmonary Ewing sarcoma remains a rare and diagnostically challenging condition requiring a high index of suspicion and multidisciplinary management. This case highlights the need for further research to optimize diagnostic and therapeutic strategies.

Research topics

  • Sarcoma Diagnosis and Treatment
  • Cardiac tumors and thrombi
  • Management of metastatic bone disease

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1055/s-0046-1826014

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.